OSWALSEEDS

ShreeOswal Seeds And Chemicals Limited

ShreeOswal Seeds And Chemicals Limited (OSWALSEEDS) financial statements and selected valuation metrics through 30 June 2026.

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Other Agricultural Products

oswalseeds.com

Ask AI

Key metrics

Price as of 2026-10-16

Stock price

₹11.87

Market cap

109 Cr

Stock P/E

8.9

P/B

2.13

ROE (FY26)

14.2%

ROCE (FY26)

12.6%

Operating margin (FY26)

5.6%

Debt / equity (FY26)

1.21

OCF / EBITDA (FY26)

-94.4%

OCF / EBITDA (3Y)

-19.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

ShreeOswal Seeds (ShreeOswal Seeds And Chemicals) is a Neemuch, Madhya Pradesh company that reports two business divisions, seeds and psyllium, with consolidated revenue of ₹248 crore in FY26.

Company snapshot

20thBy market cap

Ranked among 23 companies in Other Agricultural Products.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 50.0% of revenue

Segment	Revenue share	Revenue	PBT	Assets
Psyllium Division	50.0%	38 Cr	7 Cr	74 Cr
Seeds Division	50.0%	38 Cr	1 Cr	32 Cr

What we see

Concerns

✗Net margin is very thin at 2.9% — little room for error if costs rise.

1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Sales	66 Cr	77 Cr	43 Cr	77 Cr	68 Cr	75 Cr	26 Cr	98 Cr	39 Cr	55 Cr	56 Cr	117 Cr
Operating expenses (approx.)	63 Cr	78 Cr	48 Cr	79 Cr	66 Cr	67 Cr	24 Cr	87 Cr	43 Cr	52 Cr	52 Cr	99 Cr
EBITDA	2 Cr	-1 Cr	-5 Cr	-2 Cr	2 Cr	8 Cr	2 Cr	11 Cr	-4 Cr	3 Cr	4 Cr	18 Cr
OPM %	3.7%	-1.5%	-10.7%	-2.6%	2.3%	10.8%	7.5%	11.5%	-8.9%	5.1%	7.2%	15.7%
Other income	0.01 Cr	0.0025 Cr	0.09 Cr	0.0063 Cr	0.0028 Cr	0.05 Cr	0.24 Cr	0.07 Cr	0.0041 Cr	0.01 Cr	0.28 Cr	0.0069 Cr
Interest	1 Cr	2 Cr	2 Cr	1 Cr	0.95 Cr	0.75 Cr	1 Cr	1 Cr	0.94 Cr	1 Cr	1 Cr	1 Cr
Depreciation	0.14 Cr	0.17 Cr	0.08 Cr	0.13 Cr	0.13 Cr	0.12 Cr	0.12 Cr	0.15 Cr	0.19 Cr	0.19 Cr	0.18 Cr	0.17 Cr
Profit before tax	0.89 Cr	-3 Cr	-6 Cr	-4 Cr	0.46 Cr	7 Cr	0.94 Cr	10 Cr	-5 Cr	1 Cr	3 Cr	17 Cr
Tax %	27.8%	-14.9%	43.3%	24.4%	29.4%	26.5%	41.1%	27.9%	30.8%	27.9%	21.9%	27.4%
Net profit	0.64 Cr	-3 Cr	-4 Cr	-3 Cr	0.32 Cr	5 Cr	0.55 Cr	7 Cr	-3 Cr	1 Cr	2 Cr	12 Cr
EPS (₹)	₹0.15	₹-0.44	₹-0.38	₹-0.30	₹0.04	₹0.59	₹0.06	₹0.80	₹-0.35	₹0.11	₹0.23	₹1.34

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	272 Cr	269 Cr	246 Cr	248 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	260 Cr	268 Cr	236 Cr	234 Cr	Sign in free for the trailing twelve months
EBITDA	12 Cr	1 Cr	10 Cr	15 Cr	Sign in free for the trailing twelve months
OPM %	4.4%	0.4%	3.9%	5.9%	Sign in free for the trailing twelve months
Other income	0.12 Cr	0.11 Cr	0.30 Cr	0.37 Cr	Sign in free for the trailing twelve months
Interest	4 Cr	6 Cr	4 Cr	5 Cr	Sign in free for the trailing twelve months
Depreciation	0.43 Cr	0.52 Cr	0.50 Cr	0.71 Cr	Sign in free for the trailing twelve months
Profit before tax	8 Cr	-5 Cr	5 Cr	10 Cr	Sign in free for the trailing twelve months
Tax %	27.7%	22.6%	30.9%	24.8%	Sign in free for the trailing twelve months
Net profit	6 Cr	-4 Cr	4 Cr	7 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹3.74	₹-0.45	₹0.39	₹0.79	Sign in free for the trailing twelve months
Dividend payout %	0.0%	—	0.0%	0.0%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	15 Cr	18 Cr	18 Cr	18 Cr
Reserves	29 Cr	22 Cr	25 Cr	33 Cr
Borrowings	41 Cr	64 Cr	42 Cr	62 Cr
Other liabilities	43 Cr	20 Cr	19 Cr	28 Cr
Total liabilities	128 Cr	124 Cr	105 Cr	141 Cr
Fixed assets (net)	4 Cr	7 Cr	6 Cr	8 Cr
CWIP	1 Cr	2 Cr	2 Cr	0.85 Cr
Investments	0.0063 Cr	0.01 Cr	0.0073 Cr	0.0092 Cr
Loans & advances	0 Cr	0 Cr	0.01 Cr	0 Cr
Inventories	103 Cr	83 Cr	65 Cr	82 Cr
Trade receivables	8 Cr	17 Cr	13 Cr	35 Cr
Cash & bank	5 Cr	3 Cr	0.24 Cr	1 Cr
Other assets	7 Cr	12 Cr	18 Cr	13 Cr
Total assets	128 Cr	124 Cr	105 Cr	141 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	12 Cr	-15 Cr	24 Cr	-14 Cr
Cash from investing	-2 Cr	-3 Cr	-0.77 Cr	-0.72 Cr
Cash from financing	-6 Cr	17 Cr	-26 Cr	15 Cr
Net cash flow	3 Cr	-2 Cr	-3 Cr	1 Cr
Free cash flow (OCF − Capex)	10 Cr	-18 Cr	24 Cr	-14 Cr

Ratios

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE %	13.6%	0.6%	10.9%	12.6%
ROE %	12.9%	-10.3%	8.1%	14.2%
Debtor days	11	24	19	51
Inventory days	126	116	129	123
Days payable	3	4	8	8
Cash conversion cycle	134	135	139	165
OCF / EBITDA %	99.8%	n.m.	251.7%	-94.4%
OCF / EBITDA % (3 years)	—	—	n.m.	-19.6%
Debt / equity	0.92	1.59	0.96	1.21
Current ratio	1.49	1.35	1.56	1.49
Net debt / EBITDA	3.03	60.50	4.35	4.17